Lacticaseibacillus paracasei Bacteremia Associated With Probiotic Use in a Child With Hypoganglionosis: Case Report and Literature Review

Kohei Ukai,Koh Okamoto,Akinori Ichinose,Mariko Yoshida,Yoshimi Higurashi,Ryu Yoneda,Shuta Yamamoto,Takashi Asahara
DOI: https://doi.org/10.1097/inf.0000000000004548
2024-09-09
Abstract:Probiotics are generally considered safe and used to improve intestinal function. Here, we report a Lacticaseibacillus paracasei bacteremia case in an 8-month-old girl administered probiotics containing L. paracasei after jejunostomy for hypoganglionosis. The patient had persistent bacteremia with L. paracasei and was treated with antimicrobial therapy. The isolate from the blood culture was genetically indistinguishable to the strain contained in probiotics. Bacteremia risk should be considered before probiotic use in patients with underlying compromised immune systems or intestinal integrity.
pediatrics,immunology,infectious diseases
What problem does this paper attempt to address?